SEI INVESTMENTS CO - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q1 2022$3,158,000
-41.7%
166,930
+8.2%
0.01%
-40.0%
Q4 2021$5,414,000
+53.2%
154,334
+59.9%
0.01%
+42.9%
Q3 2021$3,535,000
+12.2%
96,548
+20.4%
0.01%0.0%
Q2 2021$3,150,000
+100.1%
80,212
+44.0%
0.01%
+75.0%
Q1 2021$1,574,000
-15.4%
55,718
-4.1%
0.00%
-20.0%
Q4 2020$1,861,000
+20.1%
58,115
+21.2%
0.01%
+25.0%
Q3 2020$1,549,00047,9450.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders